Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-026672

Chief Financial Officer acquired 19,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Horn Howard Chief Financial Officer 2024-03-01 Grant or award +19,400 99,766 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Horn Howard Chief Financial Officer 2024-03-01 Grant or award · Stock Option (Right to Buy) +34,200 34,200 D: show line 2 in the form
Loading xslF345X05/ownership.xml…